166 related articles for article (PubMed ID: 10361370)
1. [Breast cancer: the majority of women need adjuvant therapy. Even in the absence of lymphatic metastases adjuvant therapy can be useful].
Schalhorn B
Fortschr Med; 1999 Apr; 117(12):35. PubMed ID: 10361370
[No Abstract] [Full Text] [Related]
2. [Adjuvant therapy in breast cancer].
Semiglazov VF
Vopr Onkol; 2000; 46(1):18-27. PubMed ID: 10789218
[No Abstract] [Full Text] [Related]
3. [Principles of adjuvant drug therapy in breast cancer].
Castiglione M; Schnürch HG; Bender HG; Goldhirsch A
Gynakologe; 1994 Apr; 27(2):49-63. PubMed ID: 8039743
[No Abstract] [Full Text] [Related]
4. [General evaluation of adjuvant chemotherapy trials in breast cancer (excluding the Milan trial)].
Gest J
Bull Cancer; 1984; 71(4):336-44. PubMed ID: 6388672
[TBL] [Abstract][Full Text] [Related]
5. [Adjuvant therapy of breast cancer].
Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
[No Abstract] [Full Text] [Related]
6. Adjuvant systemic therapy for breast cancer.
Harris DT
Semin Oncol; 1995 Dec; 22(6):553-70. PubMed ID: 8539632
[No Abstract] [Full Text] [Related]
7. [Radiation and concomitant chemotherapy after surgery for breast cancer].
Calais G
Cancer Radiother; 2004 Feb; 8(1):39-47. PubMed ID: 15093200
[TBL] [Abstract][Full Text] [Related]
8. [Current trends in pharmacotherapy of breast cancer].
Boér K
Orv Hetil; 2002 Apr; 143(14):725-30. PubMed ID: 11975393
[TBL] [Abstract][Full Text] [Related]
9. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
[TBL] [Abstract][Full Text] [Related]
10. [Adjuvant treatment of breast cancer--routine in every case?].
Seematter RJ
Rev Med Suisse Romande; 1990 Apr; 110(4):311-3. PubMed ID: 2339228
[No Abstract] [Full Text] [Related]
11. A patient with occult breast cancer presenting with an axillary lymph node metastasis and a synchronous contralateral breast cancer.
Yirmibeşoğlu E; Tekin E; Memiş L; Yamaç D; Taneri F; Erkal HS
Breast; 2005 Apr; 14(2):157-62. PubMed ID: 15767187
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
14. [Early-stage breast cancer - strategies for adjuvant systemic therapy].
Görner M; Just M; Gerull S
Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):230-8. PubMed ID: 18716990
[TBL] [Abstract][Full Text] [Related]
15. Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.
Benchalal M; Le Prisé E; de Lafontan B; Berton-Rigaud D; Belkacemi Y; Romestaing P; Peignaux K; Courdi A; Monnier A; Montcuquet P; Goudier MJ; Marchal C; Chollet P; Abadie-Lacourtoisie S; Datchary J; Veyret C; Kerbrat P
Cancer; 2005 Jul; 104(2):240-50. PubMed ID: 15948160
[TBL] [Abstract][Full Text] [Related]
16. [Established data and practical recommendations concerning pre- and postoperative chemotherapy of rectal cancer].
Rougier P; Mitry E; Clavéro-Fabri MC; Penna C; Nordlinger B
Ann Chir; 1999; 53(10):1011-8. PubMed ID: 10670150
[TBL] [Abstract][Full Text] [Related]
17. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
[TBL] [Abstract][Full Text] [Related]
18. Elderly breast cancer patients: adjuvant chemotherapy and adjuvant endocrine therapy.
Biganzoli L; Aapro M
Gynakol Geburtshilfliche Rundsch; 2005 Jun; 45(3):137-42. PubMed ID: 15990438
[TBL] [Abstract][Full Text] [Related]
19. [Adjuvant treatment of breast cancer: past, present and future].
Piccart MJ; Paridaens RJ
Rev Med Brux; 1988 Jun; 9(5):268-73. PubMed ID: 3413370
[No Abstract] [Full Text] [Related]
20. Re: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
Kunkler I
J Natl Cancer Inst; 2005 Aug; 97(15):1162-3; author reply 1163-4. PubMed ID: 16077078
[No Abstract] [Full Text] [Related]
[Next] [New Search]
